Published in Hepatitis Weekly, December 28th, 1998
"We are extremely pleased with the results of this hepatitis B study," indicated Jean Stephenne, SB Bio. "Engerix-B is an excellent vaccine against hepatitis B for most people, and over 450 million doses have been distributed to date worldwide. But there is a need for a more powerful vaccine for those people who for a variety of reasons do not respond adequately to current vaccines. We have developed this...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly